Intercept to Present at September Investor Conference
September 03 2020 - 8:00AM
Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical
company focused on the development and commercialization of novel
therapeutics to treat progressive non-viral liver diseases, today
announced that Mark Pruzanski, M.D., President and Chief
Executive Officer and Sandip Kapadia, Chief Financial Officer of
Intercept, will present at the Wells Fargo 2020 Virtual Healthcare
Conference on Wednesday, September 9, 2020 at 12:00 p.m. ET.
A live webcast of the event will be available on the investor
page of Intercept’s website at http://ir.interceptpharma.com. An
audio archive of the webcast will also be available on Intercept’s
website for approximately two weeks.
The company will also host meetings at Baird’s 2020 Global
Healthcare Conference on September 9, 2020 and Citi’s Annual
BioPharma Virtual Conference on September 10, 2020.
About Intercept Intercept is a
biopharmaceutical company focused on the development and
commercialization of novel therapeutics to treat progressive
non-viral liver diseases, including primary biliary cholangitis
(PBC) and nonalcoholic steatohepatitis (NASH). Founded in 2002 in
New York, Intercept has operations in the United States, Europe and
Canada. For more information, please
visit www.interceptpharma.com or connect with the company
on Twitter and LinkedIn.
CONTACT
For more information about Intercept, please contact:
Investor inquiries: investors@interceptpharma.com
Media inquiries: media@interceptpharma.com
Intercept Pharmaceuticals (NASDAQ:ICPT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Intercept Pharmaceuticals (NASDAQ:ICPT)
Historical Stock Chart
From Apr 2023 to Apr 2024